Tyco Healthcare Group LP (Covidien) is recalling one lot of ReliOn sterile, single-use, disposable, hypodermic syringes with permanently affixed hypodermic needles due to possible mislabeling. The use of these syringes may lead to patients receiving an overdose of as much as 2.5 times the intended dose, which may lead to hypoglycemia, serious health consequences, and even death.
The recall applies only to Lot Number 813900 ReliOn 1cc, 31-gauge, 100 units for use with U-100 insulin distributed by Can-Am Care Corp. They are sold only at Wal-Mart stores and Sam’s Clubs under the ReliOn name and were in stores from Aug. 1, 2008, until Oct. 8, 2008.
Wal-Mart requests that all users of the aforementioned syringes return the product to their local Wal-Mart store or Sam’s Club pharmacy for a replacement.
For more information contact Covidien at 866-780-5436 or www.relion.com/recall.
Nestlé USA recalls Nestlé Nesquik Strawberry Powder
Nestlé USA is voluntarily recalling two production codes of Nestlé Nesquik Strawberry Powder 21.8 ounce that may contain small fragments of aluminum. The recall involves 21.8-ounce plastic containers woth a production code of “82255880” or “82265880” with a best by date of “August 2010.” No other Nestlé Nesquik products or production codes of Nestlé Nesquik Strawberry Powder are affected by this recall. The products were produced on August 12 and 13 and were distributed in the U.S. and in Puerto Rico. Consumers who have this product at home can return it to the store where it was purchased for a refund. Consumers with questions about the recall should call Nestlé Consumer Services Center at 888-637-4345.
Recall of mislabeled Progresso Hearty Tomato Soup
General Mills is voluntarily recalling a single day’s production of Progresso Hearty Tomato soup because of a product labeling issue. Product produced on this date may have been mislabeled, and may contain allergens not listed on the ingredient label, specifically egg, milk, and soy. Instead of getting Hearty Tomato, consumers are opening cans of its Light Vegetable and Noodle Soup.
There have been no reports of allergic reactions or illnesses associated with this product. The voluntary recall includes only 19-ounce Progresso Hearty Tomato soup with the following code date printed on the bottom of the can: 19May10 NV VN-3.
The mislabeled cans have the code date 19May10 NV VN-3 on the bottom of the can.
Consumers allergic to egg, milk or soy products, or who are unsure of whether they are allergic to egg, milk or soy products, should not consume product with a Progresso Hearty Tomato label bearing the code date 19May10 NV VN-3 on the bottom of the can, and should contact General Mills for replacement or a full refund
Consumers requesting refunds or calling with further questions should contact General Mills Consumer Services at 1-800-200-9377.
Female vets report military sexual trauma
According to preliminary research results from the Department of Veterans Affairs, approximately 15 percent of recently returned female veterans utilizing the VA health care system report experiencing sexual trauma during military service.
A cross-sectional study examined health care screening data of over 100,000 veterans of Operation Enduring Freedom in Afghanistan and Operation Iraqi Freedom who utilized medical care at any Veterans Health Administration facility during a six-year period.
Along with the more than one in seven women, 0.7 percent of males also reported having experienced military sexual trauma, or MST. Both males and females reporting MST were more likely to be diagnosed with a mental health condition than patients who did not report MST.
“These data highlight the importance of the VA’s universal screening policy,” said Joanne Pavao, MPH, a Department of Veterans Affairs researcher on the study, “as well as early intervention among veterans who have experienced sexual trauma, to prevent long-term consequences.”
VHA policy requires that all male and female veterans are screened for experiences of military sexual trauma and that free treatment for MST-related conditions is provided at all VA health care facilities.
The findings were presented at the American Public Health Association’s 136th Annual Meeting and Exposition in San Diego, Ca.